Using advanced imaging to personalize breast cancer treatment
Precision Imaging of Breast Cancer for Guiding Neoadjuvant Endocrine Therapy
This study is looking at new ways to use special imaging techniques to see how well hormone receptor positive breast cancer patients respond to early treatment, so doctors can create personalized plans that help patients get the best care faster.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Wisconsin-Madison NIH-funded |
| Lab location | 1 site (Madison, United States) |
| Project ID | NIH-10908356 on NIH RePORTER |
What this research studies
This research focuses on developing non-invasive imaging techniques to determine how well hormone receptor positive (HR+) breast cancer patients will respond to neoadjuvant endocrine therapy. By utilizing a combination of positron emission tomography and magnetic resonance imaging (PET/MRI), the study aims to assess changes in tumor sensitivity to treatment early on. The goal is to create personalized treatment plans based on individual tumor responses, potentially improving outcomes for patients with breast cancer. This approach seeks to identify effective therapies sooner, reducing the time patients spend on ineffective treatments.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with hormone receptor positive breast cancer who are about to undergo neoadjuvant endocrine therapy.
Not a fit: Patients with hormone receptor negative breast cancer or those not eligible for neoadjuvant endocrine therapy may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective and personalized treatment strategies for patients with hormone receptor positive breast cancer.
How similar studies have performed: Previous research has shown promise in using imaging techniques to assess treatment responses in cancer, indicating that this approach may yield valuable insights.
Where this research is happening
Madison, United States
- University of Wisconsin-Madison — Madison, United States (Active)
Researchers
- Principal investigator: Fowler, Amy — University of Wisconsin-Madison
- Study coordinator: Fowler, Amy
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.